Changgeng Qian
Corporate Officer/Principal presso Central South University
Profilo
Changgeng Qian is a professor at Central South University since 1992.
Prior to this, he worked as Head-Pharmacology at CytoMed, Inc. from 1992 to 1995, Senior Research Scientist at LeukoSite, Inc. from 1996 to 1999, and Senior Scientist at Millennium Pharmaceuticals, Inc. from 1999 to 2001.
From 2010 to 2012, he worked as Senior VP-Discovery & Preclinical Development at Curis, Inc. Dr. Qian holds a doctorate degree from Central South University.
Posizioni attive di Changgeng Qian
| Società | Posizione | Inizio |
|---|---|---|
| Central South University | Corporate Officer/Principal | 01/01/1992 |
Precedenti posizioni note di Changgeng Qian
| Società | Posizione | Fine |
|---|---|---|
| CURIS, INC. | Chief Tech/Sci/R&D Officer | 16/02/2012 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/05/2001 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/11/1999 |
CytoMed, Inc.
 CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a private company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Corporate Officer/Principal | 01/12/1995 |
Formazione di Changgeng Qian
| Central South University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
CytoMed, Inc.
CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a private company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Health Technology |
- Borsa valori
- Insiders
- Changgeng Qian
